Unknown

Dataset Information

0

TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.


ABSTRACT: Abstract Rats transgenic for HLA-B27 and human beta2microglobulin (B27TR) develop a multi-systemic disease resembling inflammatory bowel disease (IBD) and spondyloarthritis. TNFalpha has a crucial role in chronic inflammation. Our objective was to evaluate the effect of anti-TNFalpha treatment on spontaneous IBD in B27TR. Nine-week-old B27TR received monoclonal anti-TNFalpha or an isotypic IgG2a,k up to age of 18 weeks. A second group was monitored up to 18 weeks and then randomly assigned to anti-TNFalpha or IgG2 a,k treatment. Each rat was monitored for clinical IBD manifestations. After sacrifice, the colon was examined for pathological changes. TNFalpha receptors (TNF-R1, TNF-R2), Fas/Fas-L expression and apoptosis were evaluated. IgG2a,k-treated and untreated B27TR presented signs of IBD at 11 weeks, whereas in anti-TNFalpha-treated B27TR no IBD signs were detected. In the late treatment, IBD signs improved after 1 week. Histopathological analysis of IgG2a,k-treated B27TR colon showed inflammatory signs that were widely prevented by early anti-TNFalpha treatment. Late treatment did not significantly reduce inflammation. TNF-R1 was weakly expressed in intestinal epithelial cells of IgG2a,k-treated B27TR, while it was comparable to controls in anti-TNFalpha-treated animals. TNF-R2 immunopositivity was strongly evident in IgG2a,k-treated B27TR, whereas was absent in anti-TNFalpha-treated rats. RT-PCR confirmed these results. IgG2a,k-treated B27TR showed, at 18 weeks, few Fas-positive cells and an increase of Fas-L-positive cells. At 27 weeks, Fas-/Fas-L-positive cell number was significantly low. Anti-TNFalpha treatment increased Fas-L expression, whereas Fas increased only with the early treatment. TNFalpha blockade is effective in preventing inflammation in early phase of IBD, maintaining the homeostatic balance of apoptosis.

SUBMITTER: Milia AF 

PROVIDER: S-EPMC3823044 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.

Milia Anna Franca AF   Manetti Mirko M   Generini Sergio S   Polidori Lucia L   Benelli Gemma G   Cinelli Marina M   Messerini Luca L   Ibba-Manneschi Lidia L   Matucci-Cerinic Marco M  

Journal of cellular and molecular medicine 20080319 1


Abstract Rats transgenic for HLA-B27 and human beta2microglobulin (B27TR) develop a multi-systemic disease resembling inflammatory bowel disease (IBD) and spondyloarthritis. TNFalpha has a crucial role in chronic inflammation. Our objective was to evaluate the effect of anti-TNFalpha treatment on spontaneous IBD in B27TR. Nine-week-old B27TR received monoclonal anti-TNFalpha or an isotypic IgG2a,k up to age of 18 weeks. A second group was monitored up to 18 weeks and then randomly assigned to an  ...[more]

Similar Datasets

| S-EPMC4488392 | biostudies-literature
2009-07-17 | GSE11022 | GEO
2009-07-16 | E-GEOD-11022 | biostudies-arrayexpress
| S-EPMC4139385 | biostudies-literature
| S-EPMC5545590 | biostudies-literature
| S-EPMC5383784 | biostudies-literature
| S-EPMC3396784 | biostudies-literature
2017-02-13 | PXD005502 | Pride
| S-EPMC4219767 | biostudies-literature
| S-EPMC5018064 | biostudies-literature